Skip to main content
Download PDF

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Molecular Cancer volume 14, Article number: 128 (2015) Cite this article

The Original Article was published on 20 August 2014

Correction

After publication of this work [1], we noted that we repeatedly had a typo mistake across the manuscript. The compound we used to test our cell lines was SCH772984 and not SCH722984. The typo was found misspelled in 54 occasions, including the title.

We also wanted to add an affiliation detail to the author’s list, as noted above.

We regret the mistake and upload this note to clarify it.

Reference

  1. Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M. Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 2014;13:194. doi:10.1186/1476-4598-13-194.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), 11-934 Factor Building, Los Angeles, CA, USA

      Deborah JL Wong, Lidia Robert, Mohammad S Atefi, Amanda Lassen, Geetha Avarappatt, Michael Cerniglia, Earl Avramis, David Foulad & Antoni Ribas

    2. Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA

      Jennifer Tsoi, Thomas G Graeber, Roger S Lo & Antoni Ribas

    3. Department of Surgery, Division of Surgical-Oncology, UCLA, Los Angeles, CA, USA

      Begonya Comin-Anduix & Antoni Ribas

    4. Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA, 90095-1782, USA

      Begonya Comin-Anduix, Roger S Lo & Antoni Ribas

    5. Discovery Oncology Merck Research Laboratories, Merck Research Laboratories, Boston, Massachusetts, USA

      Ahmed Samatar

    6. Department of Medicine, Division of Dermatology, UCLA, Los Angeles, California, USA

      Roger S Lo

    7. University of Applied Sciences, Vienna, Austria

      Geetha Avarappatt

    8. Universitat Autonoma de Barcelona, UAB, Barcelona, Spain

      Lidia Robert

    Authors
    1. Deborah JL Wong
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Lidia Robert
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Mohammad S Atefi
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Amanda Lassen
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Geetha Avarappatt
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Michael Cerniglia
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Earl Avramis
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Jennifer Tsoi
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. David Foulad
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Thomas G Graeber
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Begonya Comin-Anduix
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Ahmed Samatar
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Roger S Lo
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Antoni Ribas
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Antoni Ribas.

    Additional information

    Deborah JL Wong and Lidia Robert contributed equally to this work.

    The online version of the original article can be found under doi:10.1186/1476-4598-13-194.

    Rights and permissions

    Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

    The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

    To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

    The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Wong, D.J., Robert, L., Atefi, M.S. et al. Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer 14, 128 (2015). https://doi.org/10.1186/s12943-015-0393-2

    Download citation

    • Published:

    • DOI: https://doi.org/10.1186/s12943-015-0393-2

    Molecular Cancer

    ISSN: 1476-4598